Covishield Vaccine | Government to recommend to EU to include Covishield in vaccination passport: Serum Institute Report says Serum Institute Asks Government to Take Up Covishield Inclusion In Vaccination Pas

New Delhi: The Serum Institute of India (SII) has urged the government to recommend to the European Union and other countries the inclusion of the Kovidshield vaccine in the EU COVID-19 vaccination passport. He said that failing this, students and business travelers would be affected and this could cause serious problems in the Indian and global economy. The European Union Medicines Agency (EMA) has approved only four vaccines — Pfizer/BioNtech’s Comirnati, Moderna, Astra Zeneca-Oxford’s Vaxgerviria and Johnson & Johnson’s Janssen, and only those who have received these vaccines will get a vaccination passport. And travel inside the EU will be allowed during the pandemic.

students will face problems
A source quoted SII CEO Adar Poonawalla as saying, “India has a large population. The non-inclusion of Kovidshield in the EU COVID-19 vaccination passport will prevent Kovishield vaccinated people from traveling to European countries and will cause travel difficulties for students, businessmen and this will cause major disruption to our economy and the global economy. Poonawalla told External Affairs Minister S. These things have been said by writing a letter to Jaishankar.

50 percent of the Indian population will get the Kovishield vaccine
Sources, citing Poonawalla’s letter, said that Prakash Kumar Singh, director of government and regulatory affairs at SII, has also asked Jaishankar to intervene. Singh has said, ‘If the Kovidshield vaccine is included in the EU Kovid-19 vaccination passport, then it will be in the interest of the country as well as in the interest of the people around the world.’ Poonawalla is understood to have mentioned in the letter that around 300 million people in India have been vaccinated against Kovishield and it is expected that more than 50 per cent of the Indian population will get the vaccine.

hope for a solution soon
The letter mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and the vaccine has been successfully clinically tested overseas and MHRC has approved its use for emergency use. Poonawalla said on Monday that he has taken up the issue at the highest level regarding difficulties being faced by Indians who have been vaccinated against Kovidshield in the European Union and hoped that it will be resolved soon. Given that many Indians who have been vaccinated against Kovidshield are facing problems traveling to the EU, I assure everyone that this has been taken up at the highest level and hope to resolve it soon.